Table 4 Multivariate linear regression models for BMQ-Specific dimensions: Beta coefficients (p value) (n = 712) [Only variables significant at p < 0.10 in the within-block regression models entered the multivariate final model].
Independent variables | BMQ-specific Beta coefficients (p value) | |
|---|---|---|
Concerns | Necessity | |
Female | − 0.40 (0.070) | |
Disease duration (years) | 0.04 (< 0.001) | |
SDAI (Ref. Remission) | ||
Low | 0.94 (0.056) | |
Moderate | 0.78 (0.150) | |
High | 0.98 (0.183) | |
Total number of medications (for all diseases) (Ref ≤ 5) | ||
> 5 | 0.33 (0.208) | |
Pharmacological treatment (Ref. csDMARDs) | ||
Anti-TNF | − 0.08 (0.794) | 0.84 (0.001) |
csDMARDs plus anti-TNF | 0.13 (0.714) | 1.31 (< 0.001) |
Other with or without csDMARDs | 0.61 (0.082) | 1.07 (< 0.001) |
VAS Scale | 0.15 (0.015) | |
CFQ total score | 0.12 (< 0.001) | |
HAQ total score | 0.26 (0.099) | |
F (df1, df2), p value | F (9, 701) = 7.23, p < 0.001 | F (6, 705) = 10.44, p < 0.001 |
Adj-R2 | 7.3% | 7.4% |
